原发性高血压原发性高血压的病因学尚不清楚；其多种血液动力学和病理生理学改变决非单一病因所致。

Primary hypertension: Primary (essential) hypertension is of unknown etiology; its diverse hemodynamic and pathophysiologic derangements are unlikely to result from a single cause.

目的探讨原发性高血压动物模型的建立方法.

Objective To investigate how to build animal models of primary hypertension.

目的提高原发性高血压临床疗效，减少或延缓并发症的发生。

Objective:improve the clinical therapy effect of primary hypertension, decrease or delay the complication.

目的提高原发性高血压临床疗效，减少或延缓并发症的发生。

Objective: improve the clinical therapy effect of primary hypertension, decrease or delay the complication.

结论高尿酸血症是原发性高血压合并冠心病患者的独立预测因素。

Conclusion Hyperuricemia is a independent predictor for the primary hypertension with coronary heart disease.

结论罗格列酮可作为治疗原发性高血压合并2型糖尿病的良好降压药。

Rosiglitazone Maleate can be the first choice for the treatment of primary hypertension associated with type 2 diabetes mellitus.

目的观察比较在不同血压级别的原发性高血压患者中使用阿司匹林的效果和预后。

Objective To investigate the short-time and long-time effect of aspirin during the different grades of primary hypertension.

结论倍他洛克缓释片能有效治疗轻中度原发性高血压，无明显不良反应，患者依从性良好。

Conclusions Betaloc ZOK can effectively treat the patients of mild to moderate primary hypertension with good compliance and no obvious adverse events.

高血压可分为原发性高血压和继发性高血压。

High blood pressure can be classified as primary and secondary.

结果：1）4514例高血压住院患者中原发性高血压的检出率为83.81％，继发性高血压的检出率为17.94％。

Results: 1) Of 4514 in-patients with hypertension, there were 83.81% of essential hypertension and 17.94% of secondary hypertension.